Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Adverse events following pandemic A (H1N1) 2009 monovalent vaccines in pregnant women--Taiwan, November 2009-August 2010.

Huang WT, Chen WC, Teng HJ, Huang WI, Huang YW, Hsu CW, Chuang JH.

PLoS One. 2011;6(8):e23049. doi: 10.1371/journal.pone.0023049. Epub 2011 Aug 5.

2.

The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.

Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH.

Vaccine. 2012 Mar 9;30(12):2168-72. doi: 10.1016/j.vaccine.2012.01.013. Epub 2012 Jan 17. Erratum in: Vaccine. 2012 Oct 5;30(45):6508.

PMID:
22265861
3.

Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.

Huang WT, Tang FW, Yang SE, Chih YC, Chuang JH.

Vaccine. 2014 Nov 12;32(48):6463-8. doi: 10.1016/j.vaccine.2014.09.054. Epub 2014 Oct 5.

PMID:
25285884
4.

Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.

Huang WT, Yang HW, Liao TL, Wu WJ, Yang SE, Chih YC, Chuang JH.

PLoS One. 2013;8(3):e58827. doi: 10.1371/journal.pone.0058827. Epub 2013 Mar 11.

5.

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System.

Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, Barash F, Arana J, Brantley MD, Ding H, Singleton JA, Walton K, Haber P, Lewis P, Yue X, Destefano F, Vellozzi C.

Am J Obstet Gynecol. 2011 Nov;205(5):473.e1-9. doi: 10.1016/j.ajog.2011.06.047. Epub 2011 Jun 21.

6.

Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.

Banzhoff A, Haertel S, Praus M.

Hum Vaccin. 2011 May;7(5):539-48. Epub 2011 May 1.

PMID:
21422814
7.

Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.

de Vries L, van Hunsel F, Cuppers-Maarschalkerweerd B, van Puijenbroek E, van Grootheest K.

Birth Defects Res A Clin Mol Teratol. 2014 Oct;100(10):731-8. doi: 10.1002/bdra.23243. Epub 2014 Apr 7.

PMID:
24706475
8.

Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.

Moro PL, Tepper NK, Grohskopf LA, Vellozzi C, Broder K.

Expert Rev Vaccines. 2012 Aug;11(8):911-21. Review.

PMID:
23002972
9.

A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.

Fabiani M, Bella A, Rota MC, Clagnan E, Gallo T, D'Amato M, Pezzotti P, Ferrara L, Demicheli V, Martinelli D, Prato R, Rizzo C.

Vaccine. 2015 May 5;33(19):2240-7. doi: 10.1016/j.vaccine.2015.03.041. Epub 2015 Mar 26.

PMID:
25820060
10.

Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.

Choe YJ, Cho H, Song KM, Kim JH, Han OP, Kwon YH, Bae GR, Lee HJ, Lee JK.

Jpn J Infect Dis. 2011;64(4):297-303.

11.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group.

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
12.

Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.

Kurz X, Domergue F, Slattery J, Segec A, Szmigiel A, Hidalgo-Simon A.

Vaccine. 2011 Jun 10;29(26):4378-87. doi: 10.1016/j.vaccine.2011.04.005. Epub 2011 Apr 16.

PMID:
21501644
13.

Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study.

Launay O, Krivine A, Charlier C, Truster V, Tsatsaris V, Lepercq J, Ville Y, Avenell C, Andrieu T, Rozenberg F, Artiguebielle F, Tréluyer JM, Goffinet F; Inserm COFLUPREG Study Group.

PLoS One. 2012;7(12):e52303. doi: 10.1371/journal.pone.0052303. Epub 2012 Dec 27.

14.

Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study.

Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V.

Vaccine. 2011 Aug 26;29(37):6358-65. doi: 10.1016/j.vaccine.2011.04.114. Epub 2011 May 17.

PMID:
21596080
15.
16.

Safety of pandemic H1N1 vaccines in children and adolescents.

Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.

Vaccine. 2011 Oct 6;29(43):7559-71. doi: 10.1016/j.vaccine.2011.08.016. Epub 2011 Aug 5. Review.

PMID:
21821086
17.

Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.

Huang WT, Chen WW, Yang HW, Chen WC, Chao YN, Huang YW, Chuang JH, Kuo HS.

Vaccine. 2010 Oct 18;28(44):7161-6. doi: 10.1016/j.vaccine.2010.08.069. Epub 2010 Sep 15.

PMID:
20804804
18.

Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.

Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM.

Transpl Infect Dis. 2012 Dec;14(6):564-74. doi: 10.1111/j.1399-3062.2012.00769.x. Epub 2012 Aug 13.

PMID:
22882692
19.

Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A.

BMJ. 2012 May 2;344:e2794. doi: 10.1136/bmj.e2794.

20.

Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adults.

Song JY, Cheong HJ, Seo YB, Kim IS, Noh JY, Heo JY, Choi WS, Lee J, Kim WJ.

Clin Vaccine Immunol. 2012 May;19(5):638-41. doi: 10.1128/CVI.00026-12. Epub 2012 Feb 29.

Supplemental Content

Support Center